APO Research
Talk to an analyst

APO RESEARCH · REPORT

Angiopoietin 2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Angiopoietin 2 Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchAngiopoietin 2 Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Angiopoietin 2 Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Angiopoietin 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angiopoietin 2 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Angiopoietin 2 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Angiopoietin 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Angiopoietin 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Angiopoietin 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Angiopoietin 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Angiopoietin 2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Angiopoietin 2 market include Eli Lilly and Company, Amgen Inc., Synergys Biotherapeutics, Inc., Silence Therapeutics Plc, RXi Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc., MedImmune, LLC, F. Hoffmann-La Roche Ltd. and Boehringer Ingelheim GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Angiopoietin 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Angiopoietin 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Angiopoietin 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Angiopoietin 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Angiopoietin 2 Segment by Company

Eli Lilly and Company

Amgen Inc.

Synergys Biotherapeutics, Inc.

Silence Therapeutics Plc

RXi Pharmaceuticals Corporation

Regeneron Pharmaceuticals, Inc.

MedImmune, LLC

F. Hoffmann-La Roche Ltd.

Boehringer Ingelheim GmbH

AnGes MG, Inc.

Angiopoietin 2 Segment by Type

Atu-111

BI-836880

LY-3127804

MEDI-3617

Others

Angiopoietin 2 Segment by Application

Hospital

Clinic

Others

Angiopoietin 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Angiopoietin 2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Angiopoietin 2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Angiopoietin 2 significant trends, drivers, influence factors in global and regions.

6. To analyze Angiopoietin 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiopoietin 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiopoietin 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiopoietin 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Angiopoietin 2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Angiopoietin 2 industry.

Chapter 3: Detailed analysis of Angiopoietin 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Angiopoietin 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Angiopoietin 2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Angiopoietin 2 Industry Trends Table 2. Angiopoietin 2 Industry Drivers Table 3. Angiopoietin 2 Industry Opportunities and Challenges Table 4. Angiopoietin 2 Industry Restraints Table 5. Global Angiopoietin 2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Angiopoietin 2 Revenue Share by Company (2021-2026) Table 7. Global Angiopoietin 2 Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Angiopoietin 2 Sales Volume Share by Company (2021-2026) Table 9. Global Angiopoietin 2 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Angiopoietin 2 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Angiopoietin 2 Key Company Manufacturing Base & Headquarters Table 12. Global Angiopoietin 2 Company, Product Type & Application Table 13. Global Angiopoietin 2 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Angiopoietin 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Atu-111 Table 18. Significant Companies of BI-836880 Table 19. Significant Companies of LY-3127804 Table 20. Significant Companies of MEDI-3617 Table 21. Significant Companies of Others Table 22. Global Angiopoietin 2 Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Angiopoietin 2 Sales Volume by Type (2021-2026) & (W Units) Table 24. Global Angiopoietin 2 Sales Volume by Type (2027-2032) & (W Units) Table 25. Global Angiopoietin 2 Sales Volume Share by Type (2021-2026) Table 26. Global Angiopoietin 2 Sales Volume Share by Type (2027-2032) Table 27. Global Angiopoietin 2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Angiopoietin 2 Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Angiopoietin 2 Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Angiopoietin 2 Sales Value Share by Type (2021-2026) Table 31. Global Angiopoietin 2 Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global Angiopoietin 2 Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Angiopoietin 2 Sales Volume by Application (2021-2026) & (W Units) Table 37. Global Angiopoietin 2 Sales Volume by Application (2027-2032) & (W Units) Table 38. Global Angiopoietin 2 Sales Volume Share by Application (2021-2026) Table 39. Global Angiopoietin 2 Sales Volume Share by Application (2027-2032) Table 40. Global Angiopoietin 2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Angiopoietin 2 Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Angiopoietin 2 Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Angiopoietin 2 Sales Value Share by Application (2021-2026) Table 44. Global Angiopoietin 2 Sales Value Share by Application (2027-2032) Table 45. Global Angiopoietin 2 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 46. Global Angiopoietin 2 Sales by Region (2021-2026) & (W Units) Table 47. Global Angiopoietin 2 Sales Market Share by Region (2021-2026) Table 48. Global Angiopoietin 2 Sales by Region (2027-2032) & (W Units) Table 49. Global Angiopoietin 2 Sales Market Share by Region (2027-2032) Table 50. Global Angiopoietin 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Angiopoietin 2 Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Angiopoietin 2 Sales Value Share by Region (2021-2026) Table 53. Global Angiopoietin 2 Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Angiopoietin 2 Sales Value Share by Region (2027-2032) Table 55. Global Angiopoietin 2 Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Angiopoietin 2 Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Angiopoietin 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Global Angiopoietin 2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Angiopoietin 2 Sales by Country (2021-2026) & (W Units) Table 60. Global Angiopoietin 2 Sales Market Share by Country (2021-2026) Table 61. Global Angiopoietin 2 Sales by Country (2027-2032) & (W Units) Table 62. Global Angiopoietin 2 Sales Market Share by Country (2027-2032) Table 63. Global Angiopoietin 2 Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Angiopoietin 2 Sales Value Market Share by Country (2021-2026) Table 65. Global Angiopoietin 2 Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Angiopoietin 2 Sales Value Market Share by Country (2027-2032) Table 67. Eli Lilly and Company Company Information Table 68. Eli Lilly and Company Business Overview Table 69. Eli Lilly and Company Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Eli Lilly and Company Angiopoietin 2 Product Portfolio Table 71. Eli Lilly and Company Recent Development Table 72. Amgen Inc. Company Information Table 73. Amgen Inc. Business Overview Table 74. Amgen Inc. Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Amgen Inc. Angiopoietin 2 Product Portfolio Table 76. Amgen Inc. Recent Development Table 77. Synergys Biotherapeutics, Inc. Company Information Table 78. Synergys Biotherapeutics, Inc. Business Overview Table 79. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolio Table 81. Synergys Biotherapeutics, Inc. Recent Development Table 82. Silence Therapeutics Plc Company Information Table 83. Silence Therapeutics Plc Business Overview Table 84. Silence Therapeutics Plc Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Silence Therapeutics Plc Angiopoietin 2 Product Portfolio Table 86. Silence Therapeutics Plc Recent Development Table 87. RXi Pharmaceuticals Corporation Company Information Table 88. RXi Pharmaceuticals Corporation Business Overview Table 89. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolio Table 91. RXi Pharmaceuticals Corporation Recent Development Table 92. Regeneron Pharmaceuticals, Inc. Company Information Table 93. Regeneron Pharmaceuticals, Inc. Business Overview Table 94. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolio Table 96. Regeneron Pharmaceuticals, Inc. Recent Development Table 97. MedImmune, LLC Company Information Table 98. MedImmune, LLC Business Overview Table 99. MedImmune, LLC Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. MedImmune, LLC Angiopoietin 2 Product Portfolio Table 101. MedImmune, LLC Recent Development Table 102. F. Hoffmann-La Roche Ltd. Company Information Table 103. F. Hoffmann-La Roche Ltd. Business Overview Table 104. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolio Table 106. F. Hoffmann-La Roche Ltd. Recent Development Table 107. Boehringer Ingelheim GmbH Company Information Table 108. Boehringer Ingelheim GmbH Business Overview Table 109. Boehringer Ingelheim GmbH Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolio Table 111. Boehringer Ingelheim GmbH Recent Development Table 112. AnGes MG, Inc. Company Information Table 113. AnGes MG, Inc. Business Overview Table 114. AnGes MG, Inc. Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. AnGes MG, Inc. Angiopoietin 2 Product Portfolio Table 116. AnGes MG, Inc. Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Angiopoietin 2 Distributors List Table 120. Angiopoietin 2 Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Angiopoietin 2 Product Image Figure 2. Global Angiopoietin 2 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiopoietin 2 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Angiopoietin 2 Sales (2021-2032) & (W Units) Figure 5. Global Angiopoietin 2 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Angiopoietin 2 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Atu-111 Image Figure 10. BI-836880 Image Figure 11. LY-3127804 Image Figure 12. MEDI-3617 Image Figure 13. Others Image Figure 14. Global Angiopoietin 2 Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Angiopoietin 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Angiopoietin 2 Sales Volume Share by Type (2021-2032) Figure 17. Global Angiopoietin 2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Angiopoietin 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Angiopoietin 2 Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Angiopoietin 2 Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Angiopoietin 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Angiopoietin 2 Sales Volume Share by Application (2021-2032) Figure 26. Global Angiopoietin 2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Angiopoietin 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Angiopoietin 2 Sales Value Share by Application (2021-2032) Figure 29. Global Angiopoietin 2 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 30. Global Angiopoietin 2 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Angiopoietin 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Angiopoietin 2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Angiopoietin 2 Sales Value (2021-2032) & (US$ Million) Figure 34. North America Angiopoietin 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Angiopoietin 2 Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Angiopoietin 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Angiopoietin 2 Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Angiopoietin 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Angiopoietin 2 Sales Value (2021-2032) & (US$ Million) Figure 40. South America Angiopoietin 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Angiopoietin 2 Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Angiopoietin 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Angiopoietin 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Angiopoietin 2 Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Angiopoietin 2 Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Atu-111
  • BI-836880
  • LY-3127804
  • MEDI-3617
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Eli Lilly and Company
  • Amgen Inc.
  • Synergys Biotherapeutics, Inc.
  • Silence Therapeutics Plc
  • RXi Pharmaceuticals Corporation
  • Regeneron Pharmaceuticals, Inc.
  • MedImmune, LLC
  • F. Hoffmann-La Roche Ltd.
  • Boehringer Ingelheim GmbH
  • AnGes MG, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Angiopoietin 2 Sales Value (2021-2032)
  4. 1.2.2 Global Angiopoietin 2 Sales Volume (2021-2032)
  5. 1.2.3 Global Angiopoietin 2 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Angiopoietin 2 Market Dynamics
  1. 2.1 Angiopoietin 2 Industry Trends
  2. 2.2 Angiopoietin 2 Industry Drivers
  3. 2.3 Angiopoietin 2 Industry Opportunities and Challenges
  4. 2.4 Angiopoietin 2 Industry Restraints
3 Angiopoietin 2 Market by Company
  1. 3.1 Global Angiopoietin 2 Company Revenue Ranking in 2025
  2. 3.2 Global Angiopoietin 2 Revenue by Company (2021-2026)
  3. 3.3 Global Angiopoietin 2 Sales Volume by Company (2021-2026)
  4. 3.4 Global Angiopoietin 2 Average Price by Company (2021-2026)
  5. 3.5 Global Angiopoietin 2 Company Ranking (2024-2026)
  6. 3.6 Global Angiopoietin 2 Company Manufacturing Base and Headquarters
  7. 3.7 Global Angiopoietin 2 Company Product Type and Application
  8. 3.8 Global Angiopoietin 2 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Angiopoietin 2 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Angiopoietin 2 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Angiopoietin 2 Market by Type
  1. 4.1 Angiopoietin 2 Type Introduction
  2. 4.1.1 Atu-111
  3. 4.1.2 BI-836880
  4. 4.1.3 LY-3127804
  5. 4.1.4 MEDI-3617
  6. 4.1.5 Others
  7. 4.2 Global Angiopoietin 2 Sales Volume by Type
  8. 4.2.1 Global Angiopoietin 2 Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Angiopoietin 2 Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Angiopoietin 2 Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Angiopoietin 2 Sales Value by Type
  12. 4.3.1 Global Angiopoietin 2 Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Angiopoietin 2 Sales Value by Type (2021-2032)
  14. 4.3.3 Global Angiopoietin 2 Sales Value Share by Type (2021-2032)
5 Angiopoietin 2 Market by Application
  1. 5.1 Angiopoietin 2 Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Angiopoietin 2 Sales Volume by Application
  6. 5.2.1 Global Angiopoietin 2 Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Angiopoietin 2 Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Angiopoietin 2 Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Angiopoietin 2 Sales Value by Application
  10. 5.3.1 Global Angiopoietin 2 Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Angiopoietin 2 Sales Value by Application (2021-2032)
  12. 5.3.3 Global Angiopoietin 2 Sales Value Share by Application (2021-2032)
6 Angiopoietin 2 Regional Sales and Value Analysis
  1. 6.1 Global Angiopoietin 2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Angiopoietin 2 Sales by Region (2021-2032)
  3. 6.2.1 Global Angiopoietin 2 Sales by Region: 2021-2026
  4. 6.2.2 Global Angiopoietin 2 Sales by Region (2027-2032)
  5. 6.3 Global Angiopoietin 2 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Angiopoietin 2 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Angiopoietin 2 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Angiopoietin 2 Sales Value by Region (2027-2032)
  9. 6.5 Global Angiopoietin 2 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Angiopoietin 2 Sales Value (2021-2032)
  12. 6.6.2 North America Angiopoietin 2 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Angiopoietin 2 Sales Value (2021-2032)
  15. 6.7.2 Europe Angiopoietin 2 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Angiopoietin 2 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Angiopoietin 2 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Angiopoietin 2 Sales Value (2021-2032)
  21. 6.9.2 South America Angiopoietin 2 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Angiopoietin 2 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Angiopoietin 2 Sales Value Share by Country, 2025 VS 2032
7 Angiopoietin 2 Country-level Sales and Value Analysis
  1. 7.1 Global Angiopoietin 2 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Angiopoietin 2 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Angiopoietin 2 Sales by Country (2021-2032)
  4. 7.3.1 Global Angiopoietin 2 Sales by Country (2021-2026)
  5. 7.3.2 Global Angiopoietin 2 Sales by Country (2027-2032)
  6. 7.4 Global Angiopoietin 2 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Angiopoietin 2 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Angiopoietin 2 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Angiopoietin 2 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Angiopoietin 2 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Angiopoietin 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eli Lilly and Company
  2. 8.1.1 Eli Lilly and Company Company Information
  3. 8.1.2 Eli Lilly and Company Business Overview
  4. 8.1.3 Eli Lilly and Company Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eli Lilly and Company Angiopoietin 2 Product Portfolio
  6. 8.1.5 Eli Lilly and Company Recent Developments
  7. 8.2 Amgen Inc.
  8. 8.2.1 Amgen Inc. Company Information
  9. 8.2.2 Amgen Inc. Business Overview
  10. 8.2.3 Amgen Inc. Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amgen Inc. Angiopoietin 2 Product Portfolio
  12. 8.2.5 Amgen Inc. Recent Developments
  13. 8.3 Synergys Biotherapeutics, Inc.
  14. 8.3.1 Synergys Biotherapeutics, Inc. Company Information
  15. 8.3.2 Synergys Biotherapeutics, Inc. Business Overview
  16. 8.3.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolio
  18. 8.3.5 Synergys Biotherapeutics, Inc. Recent Developments
  19. 8.4 Silence Therapeutics Plc
  20. 8.4.1 Silence Therapeutics Plc Company Information
  21. 8.4.2 Silence Therapeutics Plc Business Overview
  22. 8.4.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Silence Therapeutics Plc Angiopoietin 2 Product Portfolio
  24. 8.4.5 Silence Therapeutics Plc Recent Developments
  25. 8.5 RXi Pharmaceuticals Corporation
  26. 8.5.1 RXi Pharmaceuticals Corporation Company Information
  27. 8.5.2 RXi Pharmaceuticals Corporation Business Overview
  28. 8.5.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolio
  30. 8.5.5 RXi Pharmaceuticals Corporation Recent Developments
  31. 8.6 Regeneron Pharmaceuticals, Inc.
  32. 8.6.1 Regeneron Pharmaceuticals, Inc. Company Information
  33. 8.6.2 Regeneron Pharmaceuticals, Inc. Business Overview
  34. 8.6.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolio
  36. 8.6.5 Regeneron Pharmaceuticals, Inc. Recent Developments
  37. 8.7 MedImmune, LLC
  38. 8.7.1 MedImmune, LLC Company Information
  39. 8.7.2 MedImmune, LLC Business Overview
  40. 8.7.3 MedImmune, LLC Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MedImmune, LLC Angiopoietin 2 Product Portfolio
  42. 8.7.5 MedImmune, LLC Recent Developments
  43. 8.8 F. Hoffmann-La Roche Ltd.
  44. 8.8.1 F. Hoffmann-La Roche Ltd. Company Information
  45. 8.8.2 F. Hoffmann-La Roche Ltd. Business Overview
  46. 8.8.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolio
  48. 8.8.5 F. Hoffmann-La Roche Ltd. Recent Developments
  49. 8.9 Boehringer Ingelheim GmbH
  50. 8.9.1 Boehringer Ingelheim GmbH Company Information
  51. 8.9.2 Boehringer Ingelheim GmbH Business Overview
  52. 8.9.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolio
  54. 8.9.5 Boehringer Ingelheim GmbH Recent Developments
  55. 8.10 AnGes MG, Inc.
  56. 8.10.1 AnGes MG, Inc. Company Information
  57. 8.10.2 AnGes MG, Inc. Business Overview
  58. 8.10.3 AnGes MG, Inc. Angiopoietin 2 Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 AnGes MG, Inc. Angiopoietin 2 Product Portfolio
  60. 8.10.5 AnGes MG, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Angiopoietin 2 Value Chain Analysis
  2. 9.1.1 Angiopoietin 2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Angiopoietin 2 Sales Mode & Process
  6. 9.2 Angiopoietin 2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Angiopoietin 2 Distributors
  9. 9.2.3 Angiopoietin 2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst